The drug decitadine is currently being tested as medicine for this condition.
The drug decitadine is currently being tested as medicine for this condition. The first approved drug for the treatment of this condition was hydroxyurea, which has increased the median survival for sufferers of this condition to approximately 45 years. Persons afflicted with this condition have a higher survival rate in malaria-infested zones, although this condition often leads to small blood vessels becoming clogged, which results in vaso-occlusive crises. For 10 points, name this form of anemia that is characterized by crescent-shaped red blood cells.
The drug decitadine is currently being tested as medicine for this condition.
{sickle}-{cell} anemia [or {sickle}-{cell disease}]